Group items tagged

Opioid-induced constipation (OIC) is caused by prolonged use of certain opioids, particularly for pain management. OIC may also be caused by taking long-term and excessive doses of narcotics with effects similar to dehydration, constipation, or nausea. OIC is a common condition affecting individuals with long-standing or steady use of powerful prescription pain medications like OxyContin, codeine and morphine, as well as individuals who take sedatives frequently or individuals who have other conditions like diarrhea, kidney or liver disease, or Crohn's disease. Approval and launch of new products is expected to propel growth of the Opioid Induced Constipation Treatment Market. For instance, in September 2020, Sandoz, the generics division of Novartis AG, received a positive reimbursement decision in the UK for Rizmoic (naldemedine). The National Institute for Health and Care Excellence, U.K., issued a recommendation in favor of the option for treating opioid-induced constipation in adults, after previous laxative treatment. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/approval-and-launch-of-new-products-and.html

Launch of new products is expected to propel growth of the metabolomics market. For instance, in January 2021, JUNO Metabolomics launched the JUNO Viral Surveillance Platform based on its proprietary AI-Based Informatics System. Similarly, in June 2019, Bruker Corp. presented mass spectrometry and Nuclear Magnetic Resonance systems and other solutions for molecular phenomics and clinical metabolomics research at Metabolomics 2019. Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Integration of Artificial Intelligence (AI) with metabolomics is expected to offer lucrative growth opportunities for players in the metabolomics market. For instance, in July 2020, ReviveMed, an AI-driven drug discovery platform, collaborated with Bristol Myers Squibb for an AI-driven metabolomics study that will leverage ReviveMed's AI platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. Moreover, increasing demand for metabolomics is also expected to aid in growth of the market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/integration-of-ai-with-metabolomics-and.html

One of the most popular brain supplements is called Brain Fitness Premium, which boosts the level of fatty acids in your brain. The fatty acids boost brain function by increasing blood flow to the brain and improving neurotransmitter levels, both of which are important to brain function. Other popular brain supplements include: Brain Power Plus, Brain Boosters, Ginkgo Biloba, and Hops Strawns. All of these ingredients are proven to help improve brain function and reduce the risk of Alzheimer's. Increasing prevalence of neurological disorders is expected to propel growth of the brain health supplements market. For instance, according to Alzheimer's Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Moreover, launch of new products is also expected to aid in growth of the market. For instance, in January 2020, InnerScope Hearing Technologies Inc. launched its new Brain Health & Dietary Hearing Supplement on Walmart.com. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-neurological.html

2-day In-person Seminar Applied Statistics, with Emphasis on Risk Management in R&D, QA/QC, and Manufacturing Overview: The 2-day seminar explains how to apply statistics to manage risk in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows: ISO standards and FDA/MDD regulations regarding the use of statistics. Basic vocabulary and concepts. Statistical Process Control Statistical methods for Design Verification Statistical methods for Product/Process Qualification Metrology: the statistical analysis of measurement uncertainty, and how it is used to establish QC specifications How to craft "statistically valid conclusion statements" (e.g., for reports) Summary, from a risk management perspective Agenda Day One Lecture 1: Regulatory Requirements Lecture 2: Vocabulary and Concepts Lecture 3: Confidence Intervals (attribute and variables data) Lecture 4: Normality Tests and Normality Transformations Lecture 5: Statistical Process Control (with focus on XbarR charts) Lecture 6: Confidence/Reliability calculations for Proportions Lecture 7: Confidence/Reliability calculations for Normally distributed data (K-tables) Lecture 8: Process Capability Indices calculations(Cp, Cpk, Pp, Ppk) Day Two Lecture 1: Confidence/Reliability calculations using Reliability Plotting (e.g., for non-normal data and/or censored studies) Lecture 2: Confidence/Reliability calculations for MTTF and MTBF (this typically applies only to electronic equipment) Lecture 3: Statistical Significance: t-Tests and related "power" estimations Lecture 4: Statistical Significance: ANOVA calculations Lecture 5: Metrology (Gage R&R, Correlation, Linearity, Bias , and Uncertainty Budgets) Lecture 6: QC Sampling Plans (C=0 and Z1.4 attribute AQL plans, and alternatives to such plans) Lecture 7: Statistically valid statements for use in reports Lecture 8: Summary and Impleme

Autoclaves are also known as steam sterilizers and are used to expose each item to direct steam contact at the required temperature and pressure for the specified time. They are used for healthcare or industrial applications to eliminate the protein structure of the bacteria and spores. Compatible of steam autoclaves for crisis strategy decontamination of N95 respirators is expected to propel growth of the global steam autoclave market. For instance, in October 2020, 3M, a U.S-based multinational conglomerate corporation, announced that Belimed steam autoclaves are compatible for crisis strategy decontamination of specific single-use N95 Respirators. Moreover, launch of biological indicators for steam autoclaves is also expected to aid in growth of the market. For instance, in December 2020, Steris Corporation, a U.S-based medical equipment company, launched Spordex Self-Contained Biological Indicator Ampoules to confirm sterilization of liquids in steam autoclave cycles. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global steam autoclave market. For instance, globally, as of 4:03pm CET, 1 March 2021, there have been 113,820,168 confirmed cases of COVID-19, including 2,527,891 deaths, reported to the World Health Organization. Moreover, high prevalence of hospital-acquired infections is also expected to aid in growth of the market. For instance, according to an observational epidemiological study of intra-abdominal infections published in December 2019, in NEJM Journal Watch, of the 2621 critically ill adults with intra-abdominal infections at 309 international centers between January and December 2016, 32% were community-acquired, while 68% were hospital-acquired. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/emergence-of-covid-19-and-lunch-of-new.html

MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.

Kidney stones, also known as renal calculi, occur when the liquid stored in the kidneys becomes too concentrated. The stone, once lodged in the urinary tract, obstructs the urine flow from it and causes great pain in the abdomen. Other symptoms of a kidney stone include a burning sensation or an intense desire to urinate frequently. Also experiencing frequent urge to pass urine. Kidney stones can be treated effectively, due to presence of advanced methods and associated medical devices. Kidney stone management devices are widely used to retrieve kidney stones. Increasing prevalence of kidney stones and the increasing preference for minimally invasive surgeries worldwide is expected to propel the growth of the kidney stone management devices market. For instance, according to the United States National Kidney Foundation, every year, more than half a million people go to emergency rooms for kidney stone problems. It is estimated that one in ten people will have a kidney stone at some time in their lives. Moreover, increasing product launches, technological advancements, and increasing research and development activities for the prevention and treatment of kidney stones is expected to augment the growth of the kidney stone management devices market. For instance, in August 2020, Dornier MedTech (Dornier) announced the launch of UroX, a community that connects professionals from various disciplines to cultivate innovation and solve the most pressing challenges in urology. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-prevalence-of-kidney-stones.html

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html

Shingles is a type of skin infection that is mainly caused by the reactivation of herpes zoster or chickenpox virus. Two vaccines till now have proven successful at reducing the chances of developing shingles. One is, Zostavax, which consists of a bigger-than-usual dose of the chickenpox vaccine since shingles and chickenpox are caused by the same virus, the varicella virus. The other vaccine is called Shinglesvax, consists of an adult shingles vaccine which has been proven to be effective in preventing younger children and adults from developing shingles. If someone develops shingles after receiving either of these, they need a varicella immune globulin vaccine. The shingles vaccine is made from a weakened chickenpox virus and when used in combination with symptoms specific to shingles, it greatly reduces the risks of developing the infection. However, there is a possibility of developing more serious side effects such as a rash or muscle pain. Rare side effects include feeling faint, nausea, blurred vision, and chest pain. The factor driving the growth of the shingles vaccine market is the increased prevalence of shingles worldwide. Moreover, the rising geriatric population and the high number of launches and approval of shingle vaccines are also estimated to trigger the market growth. For instance, in August 2019, experts from the Université Laval, Québec, and Centre de research du Centre Hospitalier de l'Université de Québec found that the Shingrix vaccine developed by GSK is very effective in terms of cost and treatment than the Zostavax developed by Merck & Co. The overall effectiveness of the vaccine was 97% and has a higher effectiveness rate among the geriatric population. Shingrix right now is the main competitor of Zostavax in the market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/the-global-shingles-vaccine-market.html

The 3D cell culture market is driven by increased investment in healthcare, R&D, and other research-related activities. The novel concept of customized 3D cell culture products has allowed small companies to enter the market. Large-sized companies have focused on product launch to cater to the specific requirements of the researchers. For instance, Thermo Fisher Scientific collaborated with Applikon Biotechnology and launched two new single-use bioreactor controller platforms-i-Control and ez-Control.

Dr P.P. Singh has emerged as the best Urology Surgeon in Delhi catering the best treatment at the modest prices. He holds great knowledge in this field. Go through the official site to accumulate more information.

Cone beam computed tomography is an imaging technique that consists of X-ray computed imaging where the X-rays reflect and diverge, creating a cone-shaped beam. The cones are formed as the rays are deflected by colliding with a mirror and the resulting image is viewed from the inside of the cone. Cone-beam computed imaging uses the power of a computer to create images using the principle of diffraction and is very efficient in obtaining high quality images. Increasing prevalence of dental disorders is expected to propel growth of the global cone beam computed tomography (CBCT) market. For instance, according to the Centers for Diseases Control and Prevention's Oral Health Surveillance Report, 2019, the prevalence of untreated tooth decay in primary teeth was 10% among children aged 2-5 years and 16% among those 6-8 years during 2011-2016. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in December 2018, EhmetDX, received FDA 510(k) clearance for its 3D CBCT positioning software. The software is used to guide the position of proton beams in patient treatments. Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global cone beam computed tomography (CBCT) market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Read more @ https://sachinbhombe.blogspot.com/2021/03/increasing-prevalence-of-dental.html

Contract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a single step. Contract manufacturers usually produce vaccines at their facilities; however, some contract manufacturers also service the field through the provision of workspace and by taking care of the closing storage and final disposition of finished products. Some contract manufacturers specialize in the manufacture of one or few vaccines. Others manufacture vaccines for a number of diseases. Technological developments in biomanufacturing and biotechnology are expected to drive growth of the global vaccine contract manufacturing market. Biotechnology has witnessed significant growth in the recent past in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian biotechnology industry was valued at US$ 63 billion in 2019 and is expected to reach US$ 102 billion by 2025, registering a CAGR of 10.9%. Besides, key biotechnology and pharmaceutical companies are focused on launching vaccines for protection against infectious diseases. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/vaccine-contract-manufacturing-market.html

Medical transcription services are health reports that are typed out from dictated medical reports by medical professionals, such as doctors, dentists, and physicians. These reports contain vital information regarding a patient's health and are crucial to their care. This service offers data accuracy and data-driven insights for making an easy decision regarding patient treatment and care. Medical transcription services can be classified into Discharge Summary (DS), History and Physical Report (H&P), Operative Note or Report (OP), Consultation Report (CONSULTS), and Pathology Report (PATH) & Radiology Report. Continuous advancement in the medical transcription services market is expected to drive the growth. For instance, in October 2020, ETranscription, a Canadian transcription company, launched its new website and platform to expand its high-quality transcription services. The company has offered a free trial and reduced rates to help hospital streamline their workflow. Moreover, updates support a seamless online transcription process while delivering secure, accurate, and cost-effective services. This service effectively reduces clinical documentation time and enables doctors to plan the patient's treatments. Increasing adoption of technologies such as digital health, telemedicine, and EHR is further anticipated to foster the growth of the medical transcription services market in the near future. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/medical-transcription-services-has.html

ePharmacy as we know it today, provides pharmacy services to its customers through the use of the Internet. This technology has been around for quite some time but it wasn't until sometime ago that it started to gain popularity and slowly started replacing the traditional pharmacy. One of the advantages of using e-pharmacy over the traditional type of pharmacy is that there is no face to face interaction required between the customer and the pharmacists. Increasing adoption of smartphones is expected to propel growth of the ePharmacy market. For instance, according to Pew Research Center, 76% of adults in the U.K. owned a smartphone in 2018. Increasing geriatric population is expected to offer lucrative growth opportunities for players in the ePharmacy market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. Moreover, increasing investment in e-pharmacy is also expected to aid in growth of the market. For instance, in November 2020, Alodokter, an Indonesian telemedicine app, raised an undisclosed amount of funding from MDI Ventures, the corporate VC arm of Telkom Indonesia, in order to launch e-pharmacy. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-adoption-of-smartphones-and.html

Protein A colorimetric resins are the most extensively used affinity purifiers in bio-manufacturing and other industries. Protein A colorimetry is a robust, high-throughput chromatography method and is used primarily as a capture step because of its inherent precision. Approval and launch of new biosimilars is expected to propel growth of the protein A resin market. For instance, in December 2020, Sandoz Canada Inc., a generics and biosimilars manufacturer and a division of the Switzerland-based multinational Novartis AG, received Health Canada authorization for Hyrimoz (adalimumab injection, reference biologic drug: Humira) on November 4, 2020 for marketing in Canada. Hyrimoz, the new biosimilar, has been approved for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, hidradenitis suppurativa, psoriasis and adult uveitis. Moreover, high prevalence of chronic diseases is also expected to aid in growth of the protein A resin market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/emergence-of-covid-19-to-offer_23.html

Decline birth rate worldwide has led to the increasing adoption of various human reproductive technologies. For instance, according to the World Bank, Japan's birth rate, crude (per 1,000 people) decreased from 8.413 in 2005 to 7.4 in 2018. On the other hand, the increasing population has also led to the approval and launch of contraception products. In May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception. As the use of human reproductive technologies advances, there is increasing concern about ethical issues surrounding these medical interventions. While the use of fertility medication has been approved by the FDA, there are still questions about how to regulate it because of the fact that it is not a prescription and because of the inherent risks associated with using the technology. The first thing that we need to recognize is that the technology of artificial insemination has been around for decades. The only difference today is that we now have the ability to use technology to assist in the process of getting pregnant. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/declining-birth-rate-and-increasing.html

Enteric diseases are caused by micro-organisms such as parasites, bacteria, and viruses that cause intestinal illness. Enteric disease is caused by bacteria that are found inside of the small intestine. The term enteric describes the area where these bacteria attach to the lining of the small intestine, and it is generally thought that there are approximately five hundred different strains of this type of bacteria. An individual is not necessarily at risk for developing enteric disease, but those who have a family history of the disease are particularly at risk. Enteric diseases most often result from consuming contaminated water or food and some can spread from person to person. The emergence of COVID-19 (the novel coronavirus) is expected to propel the growth of the enteric disease testing market. For instance, according to the World Health Organization (WHO), worldwide, as of 5:01pm CET, 11 February 2021, there have been 106,991,090 confirmed cases of COVID-19, including 2,347,015 deaths. Increasing prevalence of enteric diseases worldwide and increasing launches and approvals of new products are expected to drive the enteric disease testing market growth. For instance, in October 2019, Mobidiag received CE-IVD marking for its Novodiag Stool Parasites test for the detection of intestinal parasites from stool samples. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/the-emergence-of-covid-19-to-augment.html